The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy
about
Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndromeInternational Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain.Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedsideRodent models of varicella-zoster virus neurotropism.Separate and combined effects of gabapentin and [INCREMENT]9-tetrahydrocannabinol in humans discriminating [INCREMENT]9-tetrahydrocannabinolThe Molecular and Pharmacological Mechanisms of HIV-Related Neuropathic Pain.Biosynthesis, degradation and pharmacological importance of the fatty acid amidesVaricella zoster virus-induced pain and post-herpetic neuralgia in the human host and in rodent animal models.Deciphering the mechanism(s) of action of natural products: analgesic peroxide oil as example.Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoid-neurotrophin interactions.Randomized split-mouth study on postoperative effects of palmitoylethanolamide for impacted lower third molar surgery.An update on PPAR activation by cannabinoids.Effect of palmitoylethanolamide on inflammatory and neuropathic pain in ratsEnhanced c-Fos expression in the central amygdala correlates with increased thigmotaxis in rats with peripheral nerve injury.Anxiety-like behaviour is attenuated by gabapentin, morphine and diazepam in a rodent model of HIV anti-retroviral-associated neuropathic pain.Sensory profiling in animal models of neuropathic pain: a call for back-translation.URB937, a peripherally restricted inhibitor for fatty acid amide hydrolase, reduces prostaglandin E2 -induced bladder overactivity and hyperactivity of bladder mechano-afferent nerve fibres in rats.
P2860
Q26775847-9D1BC73B-9CB5-41EA-9BD3-922823F455C1Q28298445-0F1CF16E-90CC-4022-B56B-D030D8441EDFQ33746832-34E48304-DBA7-45AB-ABA9-3000BBD474BDQ34019573-667ECC40-1407-46CA-B3B2-A772CA0068E4Q36136596-D979CF32-A1D1-4022-8C4D-5DAD3D0AA87FQ36624486-C6BEFA8E-9D5E-4A65-8FE5-F816262C2DD9Q37149019-4DD57D12-B192-4692-AB0F-64929AE8314CQ37155833-0ECBE99E-72DD-4964-AF41-4C98AD0459C1Q37625435-23C1C980-A8DC-4B2B-974F-FBEB3433B6BFQ37872360-2EF17AE1-3649-4DC7-9251-E1EE02CB5D2BQ38185071-0B1247E5-860B-4FBE-91FA-C12DE3E57CBDQ38807985-CF48EFA1-933D-438F-9327-58E3C17F23D1Q38808034-00E3FC9B-A4FE-4699-9AA7-06250C5959D0Q42379739-4E5DCB70-3475-46BE-BD6F-A4DDC30BE7BCQ42413745-D5EAE749-BD62-4E1B-951B-6034196D61FCQ43099607-AE133C71-CB59-4CED-B57E-A70F74F46D2BQ47883719-86E13BD4-DA2B-4310-8CC1-2148C707EE61Q51003882-9F4CD41B-4537-4CB2-9B86-02BC6C97833B
P2860
The effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathy
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The effect of the palmitoyleth ...... in rodent models of neuropathy
@ast
The effect of the palmitoyleth ...... in rodent models of neuropathy
@en
type
label
The effect of the palmitoyleth ...... in rodent models of neuropathy
@ast
The effect of the palmitoyleth ...... in rodent models of neuropathy
@en
prefLabel
The effect of the palmitoyleth ...... in rodent models of neuropathy
@ast
The effect of the palmitoyleth ...... in rodent models of neuropathy
@en
P2093
P2860
P356
P1476
The effect of the palmitoyleth ...... in rodent models of neuropathy
@en
P2093
A R Segerdahl
A S C Rice
D M Lambert
J Blackbeard
S Vandevoorde
V C J Wallace
P2860
P304
P356
10.1038/SJ.BJP.0707326
P407
P577
2007-06-11T00:00:00Z